![]() Alere Alere (formerly known as Inverness Medical Innovations) is a company that provides diagnostics and health management solutions for infectious, heart, and cancer-related diseases and drug addicts. | ![]() Launch Diagnostics Launch Diagnostics is an independent distributor providing diagnostic reagents and instrumentation. | Premier Allergy Premier Allergy and Asthma is a company operating as a medical clinic that diagnoses and treats patients of all ages for allergies, asthma, and other conditions. | ![]() Bioventix Bioventix is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drug of abuse testing. | |
Founding Date | Founding Date 1981 | Founding Date 1990 | Founding Date N/A | Founding Date 2003 |
Type | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations New Ash Green, GB HQ Paris, FR | Locations Dublin, US HQ | Locations Farnham, GB HQ | |
Employees | Employees 1,8642% decrease | Employees 465% increase | Employees 325% decrease | Employees 17 |
Financial | ||||
Revenue (est.) | Revenue (est.) $2.4b (FY, 2016) | Revenue (est.) £16.6m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) £13.1m (FY, 2025) |
Cost of goods | Cost of goods $1.3b (FY, 2016) | Cost of goods £10.4m (FY, 2018) | Cost of goods N/A | Cost of goods £1.1m (FY, 2025) |
Gross profit | Gross profit $1.1b (FY, 2016) | Gross profit £6.2m (FY, 2018) | Gross profit N/A | Gross profit £12m (FY, 2025) |
Net income | Net income ($137.6m) (FY, 2016) | Net income £746.2k (FY, 2018) | Net income N/A | Net income £7.6m (FY, 2025) |

Launch Diagnostics is an independent distributor providing diagnostic reagents and instrumentation.
View companyPremier Allergy and Asthma is a company operating as a medical clinic that diagnoses and treats patients of all ages for allergies, asthma, and other conditions.
View company
Bioventix is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drug of abuse testing.
View company